Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Bolam, K
At ACR Convergence 2025, researchers from Toronto and NYU reported that PsA patients starting GLP-1 receptor agonists had significant improvements in joint counts, CRP, pain scores, and DAPSA disease activity scores within one year of treatment. Whats interesting is that you dont seem to need a large dose to see these benefits
Use our peptide cost calculator to plan your budget for any protocol
Titration for researchers switching from other compounds A common question arises among researchers who have been using semaglutide or tirzepatide and want to transition to retatrutide
Gastrointestinal side effect timing Beyond nausea, GLP-1 agonists can cause constipation, diarrhea, bloating, and acid reflux
Other findings include: Overall, about one in four (26%) adults say they or someone in their household had problems paying for prescription drugs in the past year
